Discordant Cardiac Biomarkers: Frequency and Outcomes in Emergency Department Patients With Chest Pain

Annals of Emergency Medicine

Volumn 48, Issue 6, 2006, Pages 660-665

  Storrow, Alan B ^a   Lindsell, Christopher J ^b   Han, Jin H ^a   Slovis, Corey M ^a   Miller, Karen F ^a   Gibler, W Brian ^b   Hoekstra, James W ^c   Peacock, W Franklin ^d   Hollander, Judd E ^e   Pollack Jr , Charles V ^e  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; DEATH; DIAGNOSTIC TEST; ELECTROCARDIOGRAM; EMERGENCY WARD; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVASCULARIZATION; RISK; SINGAPORE; ST SEGMENT ELEVATION; THORAX PAIN; UNITED STATES;

BIOLOGICAL MARKERS; CORONARY DISEASE; CREATINE KINASE, MB FORM; ELECTROCARDIOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; REGISTRIES; SINGAPORE; TROPONIN; UNITED STATES;

EID: 33750934724     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2006.05.016     Document Type: Article

References (19)

1. Galla J.M., Mahaffey K.W., Sapp S.K., et al. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials. Am Heart J 151 (2006) 16-24
2. Newby L.K., Roe M.T., Chen A.Y., et al. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes. J Am Coll Cardiol 47 (2006) 312-318
3. GUSTO IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes: the Global Use of Strategies to Open Occluded Coronary Arteries. N Engl J Med 335 (1996) 775-782
4. PARAGON Investigators. International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina: the PARAGON Investigators: Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network. Circulation 97 (1998) 2386-2395
5. Mukherjee D., Mahaffey K.W., Moliterno D.J., et al. Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B). Am Heart J 144 (2002) 995-1002
6. PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes: the PURSUIT Trial Investigators: Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med 339 (1998) 436-443
7. Lindsell C.J., Pollack C.V., Anantharaman V., et al. The Internet Tracking Registry of Acute Coronary Syndromes (i*trACS): a multi-center registry of patients with suspicion of ACS reported using the standardized reporting guidelines for emergency department chest pain studies. Ann Emerg Med 48 (2006) 666-677
8. Alpert J.S., Thygesen K., Antman E., et al. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
9. Dillon M.C., Calbreath D.F., Dixon A.M., et al. Diagnostic problem in acute myocardial infarction: CK-MB in the absence of abnormally elevated total creatine kinase levels. Arch Intern Med 142 (1982) 33-38
10. Dorogy M.E., Hooks G.S., Cameron R.W., et al. Clinical and angiographic correlates of normal creatine kinase with increased MB isoenzymes in possible acute myocardial infarction. Am Heart J 130 (1995) 211-217
11. Hong R.A., Licht J.D., Wei J.Y., et al. Elevated CK-MB with normal total creatine kinase in suspected myocardial infarction: associated clinical findings and early prognosis. Am Heart J 111 (1986) 1041-1047
12. Lloyd-Jones D.M., Camargo Jr. C.A., Giugliano R.P., et al. Characteristics and prognosis of patients with suspected acute myocardial infarction and elevated MB relative index but normal total creatine kinase. Am J Cardiol 84 (1999) 957-962
13. Peacock W.F., Emerman C.L., McErlean E.S., et al. Normal CK, elevated MB predicts complications in acute coronary syndromes. J Emerg Med 20 (2001) 385-390
14. Pettersson T., Ohlsson O., and Tryding N. Increased CKMB (mass concentration) in patients without traditional evidence of acute myocardial infarction: a risk indicator of coronary death. Eur Heart J 13 (1992) 1387-1392
15. Vladutiu A.O., and Schachner A. Increased creatine kinase (CK) MB isoenzyme in patients with "normal" total CK activity suspected of acute myocardial infarction. J Med 20 (1989) 73-81
16. Yusuf S., Collins R., Lin L., et al. Significance of elevated MB isoenzyme with normal creatine kinase in acute myocardial infarction. Am J Cardiol 59 (1987) 245-250
17. Rao S.V., Ohman E.M., Granger C.B., et al. Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes. Am J Cardiol 91 (2003) 936-940
18. Yee K.C., Mukherjee D., Smith D.E., et al. Prognostic significance of an elevated creatine kinase in the absence of an elevated troponin I during an acute coronary syndrome. Am J Cardiol 92 (2003) 1442-1444
19. Newby L.K., Storrow A.B., Gibler W.B., et al. Bedside multimarker testing for risk stratification in chest pain units: the Chest Pain Evaluation by Creatine Kinase-MB, myoglobin, and Troponin I (CHECKMATE) Study. Circulation 103 (2001) 1832-1837